Impella Fails To Improve Mortality In Non-Randomized STOP-SHOCK
Executive Summary
Results of a study published in December found that left-side circulatory support with an Impella pump was not associated with lower 30-day mortality compared with matched cardiogenic shock patients treated with an intraaortic balloon pump (IABP) or medical therapy.